anti-FXN antibody product blog
Tags: Antibody; Monoclonal Antibody; FXN; anti-FXN antibody;
The FXN n/a (Catalog #MBS838146) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s FXN can be used in a range of immunoassay formats including, but not limited to, Immunofluorescence (IF), Western Blot (WB).IF: 1:100
WB: 1:2000. Researchers should empirically determine the suitability of the FXN n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the FXN antibody with the following immunoassay(s):
Immunofluorescence (IF) (Immunofluorescent staining of COS7 cells transiently transfected with recombinant FXN protein using FXN antibody)
Western Blot (WB) (Western Blot analysis of HEK293T cell lysates (5 ug) transfected with either recombinant FXN protein (Right) or empty vector (Left) detected with FXN antibody)
Mouse monoclonal FXN antibody.
Biological Significance: This nuclear gene encodes a mitochondrial protein which belongs to FRATAXIN family. The protein functions in regulating mitochondrial iron transport and respiration. The expansion of intronic trinucleotide repeat GAA results in Friedreich ataxia. Cross-Reactivity: Human
Immunogen: FXN antibody was raised in Mouse using full length human recombinant protein of human FXN produced in HEK293T cell as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing FXN are readily searchable from our website. Different antibodies against the same target such as FXN may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.